CN Patent

CN114728012A — 用于治疗癫痫持续状态的加奈索酮

Assigned to Immedica Pharma US Inc · Expires 2022-07-08 · 4y expired

What this patent protects

本发明涉及治疗癫痫持续状态的方法，所述方法通过向有需要的受试者施用加奈索酮静脉内推注和神经甾体持续静脉内输注进行。所述方法提供了SE抑制和SE的持续抑制。

USPTO Abstract

本发明涉及治疗癫痫持续状态的方法，所述方法通过向有需要的受试者施用加奈索酮静脉内推注和神经甾体持续静脉内输注进行。所述方法提供了SE抑制和SE的持续抑制。

Drugs covered by this patent

Patent Metadata

Patent number
CN114728012A
Jurisdiction
CN
Classification
—
Expires
2022-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Immedica Pharma US Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.